Gut Permeability Assessment in Celiac and Gluten Sensitive Children

Mayo Clinic40 enrolled

Overview

This study will assess the effect of gluten on gut barrier function. Investigators at the Mayo Clinic have developed a new gut permeability test using rhamnose (sugar \& water solution), and are hoping to prove its effectiveness in a clinical setting.

The aim of this study is to assess effect of gluten on the gut barrier function in patients at high risk for celiac disease and non-celiac gluten sensitivity (NCGS) patients. This study will assess the gut permeability in three groups of patients 1) children who are at high risk for developing celiac disease (CD) (siblings of patients with celiac disease), 2) Children who are self-diagnosed with NCGS and 3) control group of patients matched for age and gender. Patients will undergo celiac serologic and genetic testing, after which the rhamnose test will be performed to assess the presence of increased gut permeability.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Celiac Disease

Eligibility

Sex: ALLMin age: 2 YearsMax age: 17 YearsHealthy volunteers:

Medical Language ↔ Plain English

High Risk group: * Sibling with a confirmed diagnosis of celiac disease * No history Celiac disease or any other bowel disease Non-Celiac Gluten Sensitivity group: * Self-diagnosis of gluten sensitivity * No history of celiac disease or other bowel disease Healthy group: * Absence of celiac disease or any other bowel disease * No sensitivity to gluten

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Outcomes

Primary Outcomes

Gut Permeability

Assess the effect of gluten on gut permeability in children at high risk of developing celiac disease or gluten sensitivity

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.